ePrivacy and GPDR Cookie Consent by TermsFeed Generator

ORLISTAT TEVA

60MG CPS DUR 84 I

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Interruption of marketing 09.05.2022 Lék obtížně nahraditelný Capacity/distribution reasons 31.10.2022
Resumption of marketing 11.01.2022
Interruption of marketing 17.01.2022 0157949
Capacity/distribution reasons únor 2022
Resumption of marketing 21.07.2020
Interruption of marketing 20.07.2020 0157949
Manufacturing reasons 15.08.2020
Placing on the market 11.07.2019

All reports are available in the Overview.

Back to list